Clinical Trials Browser

Phase 1/2 × OTHER × Hepatic Metastasis of Colorectal Cancer × Clear all

NCT04202978 2020-04-16

Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Hepatic Metastasis of Colorectal Cancer